197 related articles for article (PubMed ID: 36342705)
1. Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.
Potnis KC; Ross JS; Aneja S; Gross CP; Richman IB
JAMA Intern Med; 2022 Dec; 182(12):1306-1312. PubMed ID: 36342705
[TBL] [Abstract][Full Text] [Related]
2. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
Zhu S; Gilbert M; Chetty I; Siddiqui F
Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract][Full Text] [Related]
4. FDA Regulation and Approval of Medical Devices: 1976-2020.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
[TBL] [Abstract][Full Text] [Related]
5. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
Clark P; Kim J; Aphinyanaphongs Y
JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
[TBL] [Abstract][Full Text] [Related]
6. Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.
Hernandez-Boussard T; Lundgren MP; Shah N
J Am Med Inform Assoc; 2021 Jun; 28(6):1353-1355. PubMed ID: 33674865
[TBL] [Abstract][Full Text] [Related]
7. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
9. FDA-regulated AI Algorithms: Trends, Strengths, and Gaps of Validation Studies.
Ebrahimian S; Kalra MK; Agarwal S; Bizzo BC; Elkholy M; Wald C; Allen B; Dreyer KJ
Acad Radiol; 2022 Apr; 29(4):559-566. PubMed ID: 34969610
[TBL] [Abstract][Full Text] [Related]
10. FDA-approved machine learning algorithms in neuroradiology: A systematic review of the current evidence for approval.
Yearley AG; Goedmakers CMW; Panahi A; Doucette J; Rana A; Ranganathan K; Smith TR
Artif Intell Med; 2023 Sep; 143():102607. PubMed ID: 37673576
[TBL] [Abstract][Full Text] [Related]
11. Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging.
Khunte M; Chae A; Wang R; Jain R; Sun Y; Sollee JR; Jiao Z; Bai HX
Clin Radiol; 2023 Feb; 78(2):123-129. PubMed ID: 36625218
[TBL] [Abstract][Full Text] [Related]
12. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.
Rathi VK; Gadkaree SK; Ross JS; Kozin ED; Sethi RK; Naunheim MR; Puram SV; Gray ST
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):608-617. PubMed ID: 28786317
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence in breast cancer screening: primary care provider preferences.
Hendrix N; Hauber B; Lee CI; Bansal A; Veenstra DL
J Am Med Inform Assoc; 2021 Jun; 28(6):1117-1124. PubMed ID: 33367670
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications.
Tau N; Shepshelovich D
JAMA Intern Med; 2020 Nov; 180(11):1420-1426. PubMed ID: 32986074
[TBL] [Abstract][Full Text] [Related]
15. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
[TBL] [Abstract][Full Text] [Related]
16. Can artificial intelligence replace ultrasound as a complementary tool to mammogram for the diagnosis of the breast cancer?
Mansour S; Kamal R; Hashem L; AlKalaawy B
Br J Radiol; 2021 Dec; 94(1128):20210820. PubMed ID: 34613796
[TBL] [Abstract][Full Text] [Related]
17. Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy.
Freeman K; Geppert J; Stinton C; Todkill D; Johnson S; Clarke A; Taylor-Phillips S
BMJ; 2021 Sep; 374():n1872. PubMed ID: 34470740
[TBL] [Abstract][Full Text] [Related]
18. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks.
Muehlematter UJ; Bluethgen C; Vokinger KN
Lancet Digit Health; 2023 Sep; 5(9):e618-e626. PubMed ID: 37625896
[TBL] [Abstract][Full Text] [Related]
19. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
[TBL] [Abstract][Full Text] [Related]
20. Effect of artificial intelligence-based computer-aided diagnosis on the screening outcomes of digital mammography: a matched cohort study.
Kim H; Choi JS; Kim K; Ko ES; Ko EY; Han BK
Eur Radiol; 2023 Oct; 33(10):7186-7198. PubMed ID: 37188881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
